Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

A sensitive HIV-1 envelope induced fusion assay identifies fusion enhancement of thrombin.

Cheng DC, Zhong GC, Su JX, Liu YH, Li Y, Wang JY, Hattori T, Ling H, Zhang FM.

Biochem Biophys Res Commun. 2010 Jan 22;391(4):1780-4. doi: 10.1016/j.bbrc.2009.12.155. Epub 2010 Jan 5.

PMID:
20045672
2.

Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene.

Sakamoto T, Ushijima H, Okitsu S, Suzuki E, Sakai K, Morikawa S, Müller WE.

J Virol Methods. 2003 Dec;114(2):159-66.

PMID:
14625051
3.

An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors.

Herschhorn A, Finzi A, Jones DM, Courter JR, Sugawara A, Smith AB 3rd, Sodroski JG.

PLoS One. 2011;6(11):e26731. doi: 10.1371/journal.pone.0026731. Epub 2011 Nov 1.

4.

Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.

Litwin V, Nagashima KA, Ryder AM, Chang CH, Carver JM, Olson WC, Alizon M, Hasel KW, Maddon PJ, Allaway GP.

J Virol. 1996 Sep;70(9):6437-41.

5.

Closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1.

Kopetzki E, Jekle A, Ji C, Rao E, Zhang J, Fischer S, Cammack N, Sankuratri S, Heilek G.

Virol J. 2008 May 1;5:56. doi: 10.1186/1743-422X-5-56.

8.
9.

Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.

Takashima K, Miyake H, Furuta RA, Fujisawa JI, Iizawa Y, Kanzaki N, Shiraishi M, Okonogi K, Baba M.

Antimicrob Agents Chemother. 2001 Dec;45(12):3538-43.

10.
11.

Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.

Lin G, Murphy SL, Gaulton GN, Hoxie JA.

J Virol Methods. 2005 Sep;128(1-2):135-42.

PMID:
15941597
12.

Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay.

Weiss CD, Barnett SW, Cacalano N, Killeen N, Littman DR, White JM.

AIDS. 1996 Mar;10(3):241-6.

PMID:
8882662
13.
15.

Development and automation of a 384-well cell fusion assay to identify inhibitors of CCR5/CD4-mediated HIV virus entry.

Bradley J, Gill J, Bertelli F, Letafat S, Corbau R, Hayter P, Harrison P, Tee A, Keighley W, Perros M, Ciaramella G, Sewing A, Williams C.

J Biomol Screen. 2004 Sep;9(6):516-24.

PMID:
15452338
16.

The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.

Rossi F, Querido B, Nimmagadda M, Cocklin S, Navas-Martín S, Martín-García J.

Retrovirology. 2008 Oct 6;5:89. doi: 10.1186/1742-4690-5-89.

17.

[Inhibition of HIV-1 mediated cell-cell fusion by saponin fraction from Psidium guajava leaf].

Mao QC, Zhou YC, Li RM, Hu YP, Liu SW, Li XJ.

Zhong Yao Cai. 2010 Nov;33(11):1751-4. Chinese.

PMID:
21434438
19.
20.

Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.

Chiba-Mizutani T, Miura H, Matsuda M, Matsuda Z, Yokomaku Y, Miyauchi K, Nishizawa M, Yamamoto N, Sugiura W.

J Clin Microbiol. 2007 Feb;45(2):477-87. Epub 2006 Dec 20.

Supplemental Content

Support Center